Cuprina Holdings (Cayman) Limited (CUPR)
NASDAQ: CUPR · Real-Time Price · USD
0.370
-0.013 (-3.47%)
At close: Mar 9, 2026, 4:00 PM EDT
0.355
-0.015 (-3.95%)
After-hours: Mar 9, 2026, 4:12 PM EDT
CUPR Employees
Cuprina Holdings (Cayman) Limited had 14 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
14
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$1,701
Profits / Employee
-$158,839
Market Cap
7.71M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 14 | 0 | - |
| Dec 31, 2023 | 14 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Harvard Bioscience | 355 |
| Jin Medical International | 273 |
| Retractable Technologies | 227 |
| Bionano Genomics | 100 |
| Precision Optics Corporation | 90 |
| Femasys | 71 |
| Ekso Bionics Holdings | 55 |
| Nephros | 31 |
CUPR News
- 3 months ago - Cuprina Holdings (Cayman) Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency - GlobeNewsWire
- 4 months ago - Cuprina Signs MOU with Singapore Biowaste Solutions to Integrate Medical Waste Management Technologies - GlobeNewsWire
- 5 months ago - Cuprina to Present Live, Answer Questions, at Skyline Signature Series™ on October 8th, 2025, at 11:00 AM ET - GlobeNewsWire
- 6 months ago - Cuprina Secures Exclusive Rights to Southeast Asia's First UNIDO/GEF- Demonstrated Medical Waste Recycling Technology - GlobeNewsWire
- 7 months ago - Are You Holding These 6 Potential Pump-And-Dump Stocks? The Bear Cave Sees These As The Next Targets - Benzinga
- 8 months ago - Cuprina Appoints Dr. Ronald Sherman, Leader in Maggot Debridement Therapy, as Medical and Scientific Director; Secures FDA-approved Medical Maggot License for U.S. Market - GlobeNewsWire
- 9 months ago - Cuprina Provides Update on Research Studies with Three Leading Education Institutes - GlobeNewsWire
- 9 months ago - Cuprina Completes Lab Able to Supply MEDIFLY Chronic Wound Therapy Across MENA Region, Secures Exclusive License to Market Medicinal Leeches in GCC Countries - GlobeNewsWire